Cargando…

One-Year Outcomes Following Intravenous Ketamine Plus Digital Training Among Patients with Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial

This secondary analysis of a randomized clinical trial examines whether automated self-association training can prolong the antidepressant effect of a single infusion of ketamine beyond 1 month in patients with treatment-resistant depression.

Detalles Bibliográficos
Autores principales:	Price, Rebecca B., Wallace, Meredith L., Mathew, Sanjay J., Howland, Robert H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167566/ https://www.ncbi.nlm.nih.gov/pubmed/37155171 http://dx.doi.org/10.1001/jamanetworkopen.2023.12434

Ejemplares similares

Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression
por: Kopelman, Jared, et al.
Publicado: (2023)

Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression
por: Rivas-Grajales, Ana Maria, et al.
Publicado: (2020)

The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression
por: O’Brien, Brittany, et al.
Publicado: (2019)

Bayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depression
por: O'Brien, Brittany, et al.
Publicado: (2019)

The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
por: Serafini, Gianluca, et al.
Publicado: (2014)

Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study
por: Włodarczyk, Adam, et al.
Publicado: (2021)

International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators
por: Price, Rebecca B., et al.
Publicado: (2022)

Apnea during slow sub-anaesthetic infusion of intravenous ketamine for treatment-resistant depression
por: Gómez-Revuelta, Marcos, et al.
Publicado: (2020)

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Zheng, Wei, et al.
Publicado: (2021)

Comparison of the effect of intravenous ketamine and intramuscular ketamine for orthopedic procedures in children's sedation
por: Momeni, Mehdi, et al.
Publicado: (2014)

The Effect of Preoperative Combined with Intravenous Lidocaine and Ketamine vs. Intravenous Ketamine on Pediatric Patients Undergoing Upper Gastrointestinal Endoscopy
por: Shafa, Amir, et al.
Publicado: (2023)

Intravenous sub-anesthetic ketamine for perioperative analgesia
por: Gorlin, Andrew W, et al.
Publicado: (2016)

Intravenous ketamine for long term anesthesia in rats
por: Linsenmeier, Robert A., et al.
Publicado: (2020)

Systematic Review of the Use of Intravenous Ketamine for Fibromyalgia
por: Pastrak, Mila, et al.
Publicado: (2021)

Comparative Effect of Intravenous Ketamine and Electroconvulsive Therapy in Major Depression: A Randomized Controlled Trial
por: Kheirabadi, Gholamreza, et al.
Publicado: (2019)

Acute cognitive effects of single-dose intravenous ketamine in major depressive and posttraumatic stress disorder
por: Davis, Margaret T., et al.
Publicado: (2021)

Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
por: Wilkowska, Alina, et al.
Publicado: (2021)

Suicide versus Accidental Death by Autoerotic Asphyxiation in a Patient Receiving Intravenous Ketamine for Depression
por: Weleff, Jeremy, et al.
Publicado: (2022)

Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management
por: Yip, Ryan, et al.
Publicado: (2022)

Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
por: Garel, Nicolas, et al.
Publicado: (2023)

Adjunct ketamine treatment of depression in treatment‐resistant schizophrenia patients is unsatisfactory in pilot and secondary follow‐up studies
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

As an analgesic ketamine versus fentanyl for total intravenous anesthesia
por: Ezici, Musa, et al.
Publicado: (2013)

Acute Antidepressant Effects of Intramuscular Versus Intravenous Ketamine
por: Chilukuri, Harihar, et al.
Publicado: (2014)

Intravenous ketamine and progressive cholangiopathy in COVID-19 patients
Publicado: (2021)

S-ketamine as an adjuvant in patient-controlled intravenous analgesia for preventing postpartum depression: a randomized controlled trial
por: Han, Yaqian, et al.
Publicado: (2022)

Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth
por: Chisamore, Noah, et al.
Publicado: (2023)

Transcranial magnetic stimulation and intravenous ketamine combination therapy for treatment-resistant bipolar depression: A case report
por: Elkrief, Laurent, et al.
Publicado: (2022)

Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder
por: Zheng, Wei, et al.
Publicado: (2023)

Retrospective data analysis to determine the effectiveness of intravenous ketamine therapy on patients suffering from depression with suicidal ideation
por: Chaudhary, Pradhyuman, et al.
Publicado: (2023)

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
por: Hashimoto, Kenji
Publicado: (2014)

Acute Antidepressant Effects of Intramuscular Versus Intravenous Ketamine: Erratum
Publicado: (2015)

The Effect of Intravenous Ketamine in Suicidal Ideation of Emergency Department Patients
por: Kashani, Parvin, et al.
Publicado: (2014)

Intravenous ketamine, propofol and propofol-ketamine combination used for pediatric dental sedation: A randomized clinical study
por: Canpolat, Dilek Gunay, et al.
Publicado: (2016)

Recurrent episodes of intractable laryngospasm followed by laryngeal and pulmonary oedema during dissociative anaesthesia with intravenous ketamine
por: Baduni, Neha, et al.
Publicado: (2010)

Does the Opioid System Block or Enhance the Antidepressant Effects of Ketamine?
por: Mathew, Sanjay J., et al.
Publicado: (2019)

NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial
por: Nierenberg, Andrew, et al.
Publicado: (2023)

Case Report of Subanesthetic Intravenous Ketamine Infusion for the Treatment of Neuropathic Pain and Depression with Suicidal Features in a Pediatric Patient
por: Weber, Garret, et al.
Publicado: (2018)

How ketamine helps to overcome depression
por: Huynh, Thu N, et al.
Publicado: (2014)

Ketamine and depression: a narrative review
por: Corriger, Alexandrine, et al.
Publicado: (2019)

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a331dol613hrvofa4gllgr5304